Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 21, 2014
Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemiaYi-Bin Chen, Shuli Li, Andrew A Lane, et al.
Bone Marrow Transplantation|October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiationZachariah DeFilipp, Shuli Li, David Avigan, et al.
Blood|March 2, 2023
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseAnita G Koshy, Haesook T Kim, Jessica Liegel, et al.
Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.
Respiratory Research|January 23, 2019
Whole blood RNA sequencing reveals a unique transcriptomic profile in patients with ARDS following hematopoietic stem cell transplantationJoshua A Englert, Michael H Cho, Andrew E Lamb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Phase II trial of parathyroid hormone after double umbilical cord blood transplantationKaren Ballen, Adam M Mendizabal, Corey Cutler, et al.
Blood Advances|September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignanciesAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Blood|August 31, 2017
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C Poe, Wei Jia, Hsuan Su, et al.
Blood Advances|November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trialVincent T Ho, Haesook T Kim, Jennifer Brock, et al.
British Journal of Haematology|July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remissionAndrew M Brunner, Shuli Li, Amir T Fathi, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 21, 2014
Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemiaYi-Bin Chen, Shuli Li, Andrew A Lane, et al.
Bone Marrow Transplantation|October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiationZachariah DeFilipp, Shuli Li, David Avigan, et al.
Blood|March 2, 2023
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseAnita G Koshy, Haesook T Kim, Jessica Liegel, et al.
Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.
Respiratory Research|January 23, 2019
Whole blood RNA sequencing reveals a unique transcriptomic profile in patients with ARDS following hematopoietic stem cell transplantationJoshua A Englert, Michael H Cho, Andrew E Lamb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Phase II trial of parathyroid hormone after double umbilical cord blood transplantationKaren Ballen, Adam M Mendizabal, Corey Cutler, et al.
Blood Advances|September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignanciesAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Blood|August 31, 2017
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C Poe, Wei Jia, Hsuan Su, et al.
Blood Advances|November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trialVincent T Ho, Haesook T Kim, Jennifer Brock, et al.
British Journal of Haematology|July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remissionAndrew M Brunner, Shuli Li, Amir T Fathi, et al.
Pageof 23